No abstract available
Keywords:
activated charcoal; andexanet; apixaban; aripazine; atrial fibrillation; dabigatran; direct thrombin inhibitor; edoxaban; factor Xa; idarucizumab; novel oral anticoagulants; prothrombin complex concentrates; recombinant factor VIIa; rivaroxaban; vitamin K antagonists; warfarin.
MeSH terms
-
Administration, Oral
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Anticoagulants / pharmacology*
-
Arginine / analogs & derivatives
-
Arginine / pharmacology
-
Blood Coagulation Factors / pharmacology
-
Factor VIIa / pharmacology
-
Factor Xa / pharmacology
-
Factor Xa Inhibitors / pharmacology
-
Humans
-
Piperazines / pharmacology
-
Recombinant Proteins / pharmacology
-
Renal Dialysis
Substances
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants
-
Blood Coagulation Factors
-
Factor Xa Inhibitors
-
PRT064445
-
Piperazines
-
Recombinant Proteins
-
prothrombin complex concentrates
-
Arginine
-
idarucizumab
-
Factor VIIa
-
Factor Xa
-
PER977